[HTML][HTML] Erlotinib inhibits growth of a patient-derived chordoma xenograft

IM Siu, J Ruzevick, Q Zhao, N Connis, Y Jiao… - PLoS …, 2013 - journals.plos.org
Chordomas are rare primary bone tumors that occur along the neuraxis. Primary treatment is
surgery, often followed by radiotherapy. Treatment options for patients with recurrence are …

[HTML][HTML] Activity of pemetrexed in pre-clinical chordoma models and humans

S Kesari, F Wang, T Juarez, S Ashili, CPK Patro… - Scientific Reports, 2023 - nature.com
Chordomas are rare slow growing tumors, arising from embryonic remnants of notochord
with a close predilection for the axial skeleton. Recurrence is common and no effective …

[HTML][HTML] Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature Review

C Noya, QG D'Alessandris, F Doglietto, R Pallini… - Cancers, 2023 - mdpi.com
Simple Summary We report the experience of our institution in treating clival chordomas
over 20 years and systematically review the recent literature, highlighting factors associated …

[HTML][HTML] Phase II study on lapatinib in advanced EGFR-positive chordoma

S Stacchiotti, E Tamborini, SL Vullo, F Bozzi… - Annals of oncology, 2013 - Elsevier
Background To report on a prospective, investigator-driven, phase II study on lapatinib in
epidermal growth factor receptor (EGFR)-positive advanced chordoma patients. Patients …

EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen

S Scheipl, M Barnard, L Cottone… - The Journal of …, 2016 - Wiley Online Library
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …

[HTML][HTML] Clival chordoma: long-term clinical outcome in a single center

Y Zhou, B Hu, Z Wu, H Cheng, M Dai, B Zhang - Medicine, 2018 - journals.lww.com
The treatment of clival chordoma remains highly challenging. This difficulty is enhanced by
the very small likelihood of a successful complete surgical resection or nonsurgical …

Chordoma: update on disease, epidemiology, biology and medical therapies

AM Frezza, L Botta, A Trama, AP Dei Tos… - Current opinion in …, 2019 - journals.lww.com
Chordoma is a complex disease because of its rarity, biological heterogeneity and peculiar
clinical behaviour. Despite the progress done, the outcome in this disease remains …

Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas

F Orzan, MR Terreni, M Longoni… - Oncology …, 2007 - spandidos-publications.com
Chordomas are rare neoplasms arising along the axial skeleton. Up to now, the most
suitable therapeutic approach is based on a combination of surgical excision and …

Enigmatic entity in childhood: clival chordoma from a tertiary center's perspective

B Bilginer, CÇ Türk, F Narin, S Hanalioglu, KK Oguz… - Acta …, 2015 - Springer
Purpose Chordoma is a rare neoplasm that arises from embryonic notochordal remnants
along the axial skeleton (ie, clivus, sacrum) and the vertebral bodies. They comprise less …

[HTML][HTML] Targeted therapy, immunotherapy, and chemotherapy for chordoma

X Yang, P Li, Z Kang, W Li - Current Medicine, 2023 - Springer
Chordoma is a rare bone tumor often present in the skull base and spine. In addition, it is not
sensitive to radiotherapy that surgical resection is of great significance for the treatment of …